VALBIOTIS (EPA:ALVAL) | WebDisclosure

Basculer en Français

10411	Companies
217812	Keywords
147362	Articles
115250	Press releases

Home
Companies
VALBIOTIS

PRESS RELEASE

published on 10/29/2024 at 17:40, 1 year 6 months ago

VALBIOTIS publie ses résultats semestriels
Valbiotis publie ses résultats semestriels avec une trésorerie de plus de 18,5 M€ et confirme sa feuille de route commerciale. Lancement réussi de Valbiotis@PRO Cholestérol en France et avancées significatives dans les études cliniques des produits TOTUM. Nouveau DAF nommé pour accompagner le pivot stratégique de l'entreprise

Résultats Semestriels Valbiotis Trésorerie Études Cliniques Feuille De Route Commerciale
BRIEF

published on 10/17/2024 at 17:45, 1 year 6 months ago

Valbiotis : Assemblée Générale Ordinaire du 5 novembre 2024

Actionnaires Contrat De Liquidité Assemblée Générale Valbiotis Compléments Alimentaires
BRIEF

published on 10/17/2024 at 17:45, 1 year 6 months ago

Valbiotis: Ordinary General Meeting of November 5, 2024

Shareholders Liquidity Contract Valbiotis General Assembly Food Supplements
PRESS RELEASE

published on 10/17/2024 at 17:40, 1 year 6 months ago

VALBIOTIS : Assemblée Générale Ordinaire du 5 novembre 2024
Valbiotis annonce son Assemblée Générale Ordinaire du 5 novembre 2024 pour permettre aux actionnaires de se prononcer sur diverses résolutions. Consultation des documents préparatoires disponible en ligne

Rachat D'actions Actionnaires Assemblée Générale Valbiotis Prévention Troubles Métaboliques
BRIEF

published on 10/15/2024 at 17:45, 1 year 7 months ago

Valbiotis célèbre le succès de l'étude INSIGHT sur TOTUM•854

Valbiotis INSIGHT Hypertension Étude Clinique TOTUM•854
BRIEF

published on 10/15/2024 at 17:45, 1 year 7 months ago

Valbiotis celebrates the success of the INSIGHT study on TOTUM•854

Valbiotis Clinical Study INSIGHT Hypertension TOTUM•854
PRESS RELEASE

published on 10/15/2024 at 17:40, 1 year 7 months ago

Valbiotis annonce le large succès de l’étude clinique INSIGHT sur TOTUM•854
Valbiotis annonce le succès de l’étude clinique INSIGHT sur TOTUM•854, démontrant son efficacité sur la réduction de la pression artérielle systolique chez des individus souffrant d'hypertension légère non traitée

Valbiotis Efficacité Étude Clinique TOTUM•854 Hypertension Légère
PRESS RELEASE

published on 10/15/2024 at 17:40, 1 year 7 months ago

Valbiotis announces the major success of the INSIGHT clinical study on TOTUM•854
Valbiotis announces major success of INSIGHT clinical study on TOTUM 854, demonstrating efficacy in reducing systolic blood pressure in individuals with untreated mild hypertension. Validation of innovative plant-based active ingredients

Valbiotis Plant-based INSIGHT Clinical Study TOTUM 854 Systolic Blood Pressure
BRIEF

published on 10/09/2024 at 17:50, 1 year 7 months ago

Valbiotis : Informations sur les droits de vote et actions, septembre 2024

Droits De Vote Capital Social Euronext Growth Valbiotis Franchissements De Seuil
BRIEF

published on 10/09/2024 at 17:50, 1 year 7 months ago

Valbiotis: Information on voting rights and shares, September 2024

Share Capital Voting Rights Euronext Growth Valbiotis Threshold Crossings

Accesswire

Published on 05/16/2026 at 01:15, 16 hours 54 minutes ago

Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 01:00, 17 hours 9 minutes ago

Arctic Fox Adopts Semi-Annual Reporting
Published on 05/16/2026 at 00:00, 18 hours 9 minutes ago

Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 18 hours 59 minutes ago

Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 19 hours 9 minutes ago

Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency

View all ACCESSWIRE

EQS Group

Published on 05/16/2026 at 16:08, 2 hours ago

The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 21 hours 59 minutes ago

CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:30, 23 hours 39 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:30, 23 hours 39 minutes ago

Designated Person Notifications
Published on 05/15/2026 at 18:10, 23 hours 59 minutes ago

Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success

Les Echos

Published on 05/15/2026 at 15:08, 1 day 3 hours ago

Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 3 hours ago

Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 7 hours ago

Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 9 hours ago

Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days ago

ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES

View all LES ECHOS COMFI WIRE